Young Caroline has demonstrated a consistent buying pattern in CPIX (Cumberland Pharmaceuticals), with no recorded sales across 149 transactions totaling $7,557.78 in purchases. The most recent activity includes a notable $5,040 acquisition on March 18, 2026, classified as a discretionary trade (Code A), marking the largest single purchase in the dataset. Prior to this, Caroline executed a series of smaller buys (Code L) between late November and December 2025, with daily transactions ranging from $6.96 to $19.55. The frequency of these purchases—often consecutive trading days—suggests a deliberate accumulation strategy, particularly during December when 18 transactions averaged approximately $8.50 per trade.
The absence of any sell-side activity across all filings indicates a long-term holding bias toward CPIX. While the December 2025 trades were modest in size—none exceeding $20—the March 2026 purchase represents a significant escalation in position size, exceeding the cumulative value of the preceding 25 transactions. The pattern lacks recent activity beyond the March trade, leaving open whether this marks a pause or conclusion to the accumulation phase. All transactions were executed at prevailing market prices, with no derivative instruments or indirect ownership reported. The data reflects a retail-scale investment approach focused exclusively on one microcap pharmaceutical stock.
AI-assisted summary